SBIR-STTR Award

Polar sampling and optimization of protein-ligand cocrystal structures
Award last edited on: 11/13/2019

Sponsored Program
STTR
Awarding Agency
NIH : NIGMS
Total Award Amount
$224,934
Award Phase
1
Solicitation Topic Code
NIGMS
Principal Investigator
Charles H Reynolds

Company Information

Gfree Bio LLC

3805 Old Eaton Road
Doylestown, PA 18902
   (215) 362-1428
   N/A
   www.gfreebio.com

Research Institution

----------

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2016
Phase I Amount
$224,934
Gfree Bio proposes to collaborate with Professor Bajaj and his group at the University of Texas to develop a general and much more theoretically rigorous algorithm for fitting the ligand binding region of experimental protein-ligand cocrystal structures. Current methods and practices often lead to very poor geometries for the bound ligand. This is a significant impediment to the most effective use of crystallography in drug discovery. We will solve this problem by developing an automated method for using polar sampling and optimization in conjunction with the experimental electron density information to correct protein-ligand cocrystal structures. This methodology will capitalize on recent advances in the Bajaj lab with respect to fast multidimensional optimization, linear scaling electrostatics and solvation methods, and advanced data structures for representing molecular systems. This software has great commercial potential since the problem of properly fitting bound ligands has been receiving increasing attention in the literature, and industry. As such our solution will have broad impact on structure-based drug design.

Public Health Relevance Statement:


Public Health Relevance:
Gfree Bio will collaborate with Professor Bajaj's group at the University of Texas at Austin to develop a new method to solve the problem of ill-defined ligand geometries in protein-ligand cocrystal structures. This program will provide significantly better starting points for structure-based design of new drug candidates and contribute to academic and commercial efforts to develop new treatments for a range of diseases.

Project Terms:
Accounting; Algorithms; Amides; Attention; austin; base; Binding; Binding Proteins; Biological; Chemicals; commercialization; Complement; Complex; Computer software; Crystallography; Data; density; design; Development; Disease; drug candidate; Drug Design; drug discovery; electron density; Electrostatics; Ensure; Environment; Geometry; Imagery; improved; Industry; Iridium; Lead; Ligand Binding; Ligands; Light; Literature; Maps; Marketing; Methodology; Methods; Modeling; Molecular; Molecular Conformation; novel; novel therapeutics; Phase; Problem Solving; Productivity; professor; programs; prospective; protein structure; Proteins; Protocols documentation; prototype; public health relevance; Resolution; Sampling; Scientist; Services; sound; Structure; System; Techniques; Testing; Texas; tool; Uncertainty; Universities; Visual; Work

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
----
Phase II Amount
----